December 2021

Column

Trending From ACCC

Leveraging Telehealth to Provide Supportive Care to Patients With Metastatic Breast Cancer

12/15/2021

Association of Community Cancer Centers

Patients with metastatic breast cancer facing disparities in care can benefit from telehealth services by saving time and receiving much of their care at home through virtual appointments, patient portal communications, and online education.

Patients with metastatic breast...

12/15/2021

Journal of Clinical Pathways

COA Viewpoint

Don’t Throw Away Community Oncology’s Hard Work: Extend the Oncology Care Model

12/15/2021

Fred Schnell, MD, FACP, Chief Medical Officer, Community Oncology Alliance

Authors from the Community Oncology Alliance explore what could be next for practices seeking continual improvement in the Oncology Care Model, a multimillion dollar, years-long program that has helped community oncology practices transform...

Authors from the Community...

12/15/2021

Journal of Clinical Pathways

Editor's Page

The Path Ahead

12/15/2021

Winston Wong, PharmD, Editor-in-Chief

Winston Wong, PharmD, reflects on the Journal of Clinical Pathways' accomplishments in 2021, and discusses the positive changes to come in 2022.

Winston Wong, PharmD, reflects...

12/15/2021

Journal of Clinical Pathways

Pharma Insights

Self-Reported Health Care Resource Utilization in Clinical Trials

12/15/2021

Ronaé McLin, MPH

Marissa Baker-Wagner, MPH

Bridget Healey, MPH

Anh Thy H. Nguyen, MSPH

Ronaé McLin, MPH, and colleagues explore the benefits and limitations of collecting HCRU within a clinical trial, as well as recommendations for how to do so in a way that will yield the most useful data.

Ronaé McLin, MPH, and colleagues...

12/15/2021

Journal of Clinical Pathways

Health Systems Insights

The Opportunity for Providers to Adopt the Concept of Population Health Care

12/15/2021

Joshua M. Liao, MD, MSc

Joshua M. Liao, MD, MSc, describes population health definitions and articulates an opportunity for providers to align their work under the concept of population health care.

Joshua M. Liao, MD, MSc,...

12/15/2021

Journal of Clinical Pathways

Clinical Pathways GPS

Waste Not Want Not...Role of Clinical Pathways In Rx Waste Management

12/15/2021

Richard G. Stefanacci, DO, MGH, MBA, AGSF, CMD

Richard G. Stefanacci, DO, MGH, MBA, AGSF, CMD, discusses reasons why pharmaceutical waste management is emerging as a new major public and environmental health concern.

Richard G. Stefanacci, DO, MGH,...

12/15/2021

Journal of Clinical Pathways

Sponsored

Elsevier Partner Spotlight

Reducing Cost of Care With Clinical Pathways at a Large Academic Medical Center

12/15/2021

Adam F Binder, MD; Nathan R Handley, MD, MBA; Valerie P Csik, MPH, CPPS, Sidney Kimmel Cancer Center; Department of Medical Oncology, Thomas Jefferson University

Adam F Binder, MD; Nathan R Handley, ...

Study findings reinforce the potential value of clinical pathway tools for oncologists administering chemotherapy.

Study findings reinforce the...

12/15/2021

Journal of Clinical Pathways

Feature

Research Reports

Costs of Extended Use of the Immune Checkpoint Inhibitors in First-line Non-Small Cell Lung Cancer

12/15/2021

Helmy M Guirgis, MD, PhD

Helmy M Guirgis, MD, PhD, aimed to examine cost of extended immune checkpoint inhibitor use beyond their indications in advanced/metastatic non-small cell lung cancer.

Helmy M Guirgis, MD, PhD, aimed...

12/15/2021

Journal of Clinical Pathways

Current Issue

June 2024

Volume 10

Issue 3

Current Issue

Issue Archive

Special Reports

Sponsored

Special Report

Shedding Light on Non-Small Cell Lung Cancer & Its Impact on Patients

04/03/2023

This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.

This supplement aims to raise...

04/03/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Brukinsa® (Zanubrutinib) for Chronic Lymphocytic Leukemia

03/31/2023

In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...

In this product monograph, read...

03/31/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Tumor Lysis Syndrome: Early Diagnosis and Management

01/04/2023

This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...

This review summarizes the...

01/04/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients

08/09/2022

In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.

In an interview with Journal of...

08/09/2022

Journal of Clinical Pathways

Updated NCCN Guidelines on B-Cell Lymphomas

Sponsored

JCP Special Report

Overview of the Updated NCCN Guidelines on B-Cell Lymphomas

06/15/2022

Robert Fee

Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.

Updated multiple times in 2022,...

06/15/2022

Journal of Clinical Pathways

Sponsored

Special Report

Expanded Indication for Zanubrutinib: Marginal Zone Lymphoma and Waldenström’s Macroglobulinemia

06/10/2022

In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.

In an interview with Journal of...

06/10/2022

Journal of Clinical Pathways

JCP Special Report

Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group

05/20/2022

Winston Wong, PharmD

Gordon Kuntz

Robin T Zon, MD, FACP, FASCO

2021 Care Pathways Working Group

The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...

The Journal of Clinical Pathways...

05/20/2022

Journal of Clinical Pathways

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

Sponsored

Special Report

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

12/15/2021

Deborah Abrams Kaplan

NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.

NCCN released updates to its...

12/15/2021

Journal of Clinical Pathways

Sponsored

Special Report

Navigating the Patient Journey for Unresectable Stage III Non-Small Cell Lung Cancer

09/16/2021

.ryan-test { display: none; } .body-content h3 { font-size: 18px; line-height: 18px; color: #000000; font-weight: 600px; } .related-content { display: none; } .body-content div > div:nth-of-type(3) .paragraph > h3 >...

.ryan-test { display:...

09/16/2021

Journal of Clinical Pathways

$Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma$

Special Report

Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma

01/14/2021

Journal of Clinical Pathways

Journal of Clinical Pathways Newsletter

Editorial Correspondence

December 2021

Column

Feature

Current Issue

Special Reports

Subscribe

December 2021 Volume 7 Issue 10

Specialties

Events

Year Round Education

HMP Global Products